Annual CFI
-$204.08 M
-$287.39 M-344.96%
December 31, 2024
Summary
- As of March 14, 2025, DYN annual cash flow from investing activities is -$204.08 million, with the most recent change of -$287.39 million (-344.96%) on December 31, 2024.
- During the last 3 years, DYN annual CFI has fallen by -$66.18 million (-48.00%).
- DYN annual CFI is now -334.03% below its all-time high of $87.20 million, reached on December 31, 2022.
Performance
DYN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$16.01 M
+$3.39 M+17.49%
December 31, 2024
Summary
- As of March 14, 2025, DYN quarterly cash flow from investing activities is -$16.01 million, with the most recent change of +$3.39 million (+17.49%) on December 31, 2024.
- Over the past year, DYN quarterly CFI has dropped by -$27.18 million (-243.28%).
- DYN quarterly CFI is now -130.99% below its all-time high of $51.66 million, reached on September 30, 2022.
Performance
DYN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$204.08 M
-$42.21 M-26.07%
December 31, 2024
Summary
- As of March 14, 2025, DYN TTM cash flow from investing activities is -$204.08 million, with the most recent change of -$42.21 million (-26.07%) on December 31, 2024.
- Over the past year, DYN TTM CFI has dropped by -$74.43 million (-57.41%).
- DYN TTM CFI is now -275.32% below its all-time high of $116.40 million, reached on March 31, 2023.
Performance
DYN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
DYN Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -345.0% | -243.3% | -57.4% |
| 3 y3 years | -48.0% | -192.9% | -277.2% |
| 5 y5 years | -10000.0% | -192.9% | -277.2% |
DYN Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -334.0% | at low | -131.0% | +91.1% | -275.3% | at low |
| 5 y | 5-year | -334.0% | at low | -131.0% | +91.1% | -275.3% | at low |
| alltime | all time | -334.0% | at low | -131.0% | +91.1% | -275.3% | at low |
Dyne Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$204.08 M(-345.0%) | -$16.01 M(-17.5%) | -$204.08 M(+26.1%) |
| Sep 2024 | - | -$19.40 M(-273.6%) | -$161.87 M(+24.9%) |
| Jun 2024 | - | $11.17 M(-106.2%) | -$129.65 M(+4.9%) |
| Mar 2024 | - | -$179.84 M(-786.5%) | -$123.59 M(-248.3%) |
| Dec 2023 | $83.31 M(-4.5%) | $26.20 M(+104.3%) | $83.31 M(+9.1%) |
| Sep 2023 | - | $12.82 M(-25.6%) | $76.35 M(-33.7%) |
| Jun 2023 | - | $17.23 M(-36.3%) | $115.19 M(-1.0%) |
| Mar 2023 | - | $27.06 M(+40.7%) | $116.40 M(+33.5%) |
| Dec 2022 | $87.20 M | $19.24 M(-62.8%) | $87.20 M(+28.7%) |
| Sep 2022 | - | $51.66 M(+180.1%) | $67.73 M(+412.2%) |
| Jun 2022 | - | $18.44 M(-963.4%) | $13.22 M(-213.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.14 M(+808.9%) | -$11.65 M(-91.5%) |
| Dec 2021 | -$137.89 M(+202.0%) | -$235.00 K(-91.7%) | -$137.89 M(-24.6%) |
| Sep 2021 | - | -$2.85 M(-55.7%) | -$182.88 M(+1.5%) |
| Jun 2021 | - | -$6.43 M(-95.0%) | -$180.19 M(+3.7%) |
| Mar 2021 | - | -$128.38 M(+183.9%) | -$173.82 M(+280.7%) |
| Dec 2020 | -$45.66 M(+2672.4%) | -$45.22 M(>+9900.0%) | -$45.66 M(>+9900.0%) |
| Sep 2020 | - | -$156.00 K(+119.7%) | -$438.00 K(+55.3%) |
| Jun 2020 | - | -$71.00 K(-66.4%) | -$282.00 K(+33.6%) |
| Mar 2020 | - | -$211.00 K | -$211.00 K |
| Dec 2019 | -$1.65 M(+1129.1%) | - | - |
| Dec 2018 | -$134.00 K | - | - |
FAQ
- What is Dyne Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Dyne Therapeutics?
- What is Dyne Therapeutics annual CFI year-on-year change?
- What is Dyne Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly CFI year-on-year change?
- What is Dyne Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Dyne Therapeutics?
- What is Dyne Therapeutics TTM CFI year-on-year change?
What is Dyne Therapeutics annual cash flow from investing activities?
The current annual CFI of DYN is -$204.08 M
What is the all time high annual CFI for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash flow from investing activities is $87.20 M
What is Dyne Therapeutics annual CFI year-on-year change?
Over the past year, DYN annual cash flow from investing activities has changed by -$287.39 M (-344.96%)
What is Dyne Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of DYN is -$16.01 M
What is the all time high quarterly CFI for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash flow from investing activities is $51.66 M
What is Dyne Therapeutics quarterly CFI year-on-year change?
Over the past year, DYN quarterly cash flow from investing activities has changed by -$27.18 M (-243.28%)
What is Dyne Therapeutics TTM cash flow from investing activities?
The current TTM CFI of DYN is -$204.08 M
What is the all time high TTM CFI for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM cash flow from investing activities is $116.40 M
What is Dyne Therapeutics TTM CFI year-on-year change?
Over the past year, DYN TTM cash flow from investing activities has changed by -$74.43 M (-57.41%)